GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Corix Bioscience CXBS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Corix Bioscience

Its shares trade under the ticker CXBS. It has been listed since 8 April 2009. In the fiscal year to 31 December 2016, it reported revenue of $693,621 and a net loss of $4.4m. At that date it held total assets of $11.4m and shareholders' equity of $4.5m.

Corix Bioscience, Inc. is an emerging growth company, which engages in the provision, extraction, and cultivation of cannabidiol. The company is headquartered in Irvine, California. The company went IPO on 2009-04-08. The firm is engaged in providing cannabidiol (CBD) oil, which is used for a wide variety of medicinal purposes. The company is also engaged in cultivating and extracting tetrahydrocannabivarin (THCV) oil. The company clones all of its plants based off of three original types: Otto, Cherry Wine and Georges Pet. The company operates in Oregon, California and Nevada, United States.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
8 Apr 2009

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Corix Bioscience Inc. possesses several strengths that contribute to its competitive advantage:

Weaknesses

  • Despite its strengths, Corix Bioscience Inc. also has a number of weaknesses that may hinder its performance:

Opportunities

  • Corix Bioscience Inc. can leverage the following opportunities to further grow and expand its business:

Threats

  • Corix Bioscience Inc. should also be aware of the following threats that may impact its operations:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.